Search

Your search keyword '"Wechalekar, Ashutosh D."' showing total 832 results

Search Constraints

Start Over You searched for: Author "Wechalekar, Ashutosh D." Remove constraint Author: "Wechalekar, Ashutosh D."
832 results on '"Wechalekar, Ashutosh D."'

Search Results

4. Correction: “The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms” Leukemia. 2022 Jul;36(7):1720–1748

5. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms

7. Complete responses in AL amyloidosis are unequal: the impact of free light chain mass spectrometry in AL amyloidosis

8. Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDA

10. Response rates to second‐line treatment with daratumumab bortezomib dexamethasone (DVD) in relapsed/refractory light chain amyloidosis (AL) after initial Bortezomib‐based regime

16. High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis

17. Redefining Cardiac Involvement and Targets of Treatment in Systemic Immunoglobulin AL Amyloidosis

19. Moving towards establishing centres of excellence in cardiac amyloidosis: an International Cardio-Oncology Society statement.

20. Standardized reporting of monoclonal immunoglobulin–associated renal diseases: recommendations from a Mayo Clinic/Renal Pathology Society Working Group

22. Real‐world efficacy of single‐agent belantamab mafodotin in relapsed systemic AL amyloidosis

26. Deep phenotyping of p.(V142I)‐associated variant ATTR amyloid cardiomyopathy: distinct from wild‐type ATTR amyloidosis?

27. Clinical and clonal characteristics of monoclonal immunoglobulin M‐associated type I cryoglobulinaemia

28. Myocardial Edema and Prognosis in Amyloidosis

29. Molecular genetic investigation, clinical features, and response to treatment in 21 patients with Schnitzler syndrome

30. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the International Kidney and Monoclonal Gammopathy Research Group

34. Deep phenotyping of p.(V142I)‐associated variant transthyretin amyloid cardiomyopathy: Distinct from wild‐type transthyretin amyloidosis?

35. Clinical and clonal characteristics of monoclonal immunoglobulin M‐associated type I cryoglobulinaemia.

36. Assessing the prognostic utility of hematologic response for overall survival in patients with newly diagnosed AL amyloidosis: results of a meta-analysis.

37. Amyloidosis Diagnosed in Solid Organ Transplant Recipients

39. Tc-99m labelled bone scintigraphy in suspected cardiac amyloidosis

42. Natural History, Quality of Life, and Outcome in Cardiac Transthyretin Amyloidosis

44. Quality of Life and Symptoms Among Patients With Relapsed/Refractory AL Amyloidosis Treated With Ixazomib‐Dexamethasone Versus Physician's Choice

49. Efficacy and Safety of Belantamab Mafodotin Monotherapy in Patients with Relapsed or Refractory Light Chain Amyloidosis: A Phase 2 Study By the European Myeloma Network

50. Survey of the Relevance of Quality of Life (QoL) Questionnaires (QoLQs) Currently Used to Evaluate Multiple Myeloma (MM) Patients' Qol in Real-World MM Patients and Healthcare Professionals (HCPs)

Catalog

Books, media, physical & digital resources